መነሻ › ሂድራዴኒቲስ ሴፕራቲቫ › ኢሊኖይ
በኢሊኖይ ለሂድራዴኒቲስ ሴፕራቲቫ የሚደረጉ ክሊኒካዊ ጥናቶች
ለሂድራዴኒቲስ ሴፕራቲቫ የሚደረጉ 6 ጥናቶች በኢሊኖይ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በኢሊኖይ ውስጥ ያሉ ከተሞች
Official study text (English)
An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
- Endeavor Health, Glenview
- Dundee Dermatology, West Dundee
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT07665437ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa
- Oruka Therapeutics Investigative Site, Chicago
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 79 · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT07783542A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
- NorthShore University Health System - Endeavor Health Medical Group - Skokie - Woods Drive- Site Number : 8400019, Skokie
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07225569Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
- Investigative Site US125, Chicago
- Investigative Site US093, Chicago
- Investigative Site US039, West Dundee
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ሴፕቴ 2026 · NCT06855498Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
- Endeavor Health Medical Group, Skokie
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ12 እስከ 17 · ሁሉም ጾታዎች · የተሻሻለው በ6 ኦገስ 2026 · NCT07213973A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
- Northwestern University, Chicago
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ18 እስከ 71 · ሁሉም ጾታዎች · የተሻሻለው በ16 ኤፕሪ 2026 · NCT07123038ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።